蓝箭航天IPO被抽中现场检查

Core Viewpoint - The article discusses the first batch of IPO companies for the Science and Technology Innovation Board (STAR Market) in 2026, highlighting their business focus and the implications of the recent onsite inspection process for these companies [2][6]. Group 1: IPO Companies Overview - Six companies have been selected for onsite inspections as part of their IPO application process: 1. FrequenLaser: Focuses on high-end fiber laser technology for quantum information, LiDAR, advanced industrial applications, and medical aesthetics [2]. 2. Hanno Medical: A high-end innovative medical device company specializing in extracorporeal life support (ECLS) technology, with its core product, Lifemotion® ECMO system, launched in 2023 [3]. 3. Gaoke Technology: Engaged in the development and production of precision fluid control components, including intelligent dispensing robots and laser soldering systems [3]. 4. Taosheng Technology: A leading provider of professional testing interface products in the semiconductor field, serving over 600 global clients [4]. 5. Ruisichuangxin: Specializes in the R&D and manufacturing of RF front-end devices for 4G/5G, recognized as a national-level specialized and innovative small giant enterprise [5]. 6. Blue Arrow Aerospace: Focuses on the development and production of liquid oxygen-methane engines and launch services, aiming to build a comprehensive aerospace technology ecosystem [6]. Group 2: Onsite Inspection Implications - The onsite inspection process may delay the IPO application review for these companies, as it requires time for rectification of any identified issues [6][7]. - Industry experts suggest that while the inspection may raise questions, it does not necessarily indicate problems with the companies, as many firms are well-prepared for such evaluations [7]. - The recent policy changes encouraging hard technology innovation have shifted the focus of IPO reviews from profitability to technological capability and growth potential [7].